.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2014 for a whopping $43 bil...
.On the heels of a period 3 succeed that failed to wow clients, Ironwood Pharmaceuticals is actually...
.Don't stop Monte Rosa Therapies currently. The Boston-based biotech is actually enjoying after sign...
.Invite to this week's Chutes & Ladders, our summary of significant leadership hirings, firings a...
.Commemorating his provider's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer call...
.AbbVie has actually returned to the resource of its antipsychotic powerhouse Vraylar in search of y...
.GenSight Biologics is weeks out of running out of funds. Once again. The biotech only has adequate ...
.Monopar Therapeutics is recuperating a medicine coming from the dump of AstraZeneca's uncommon ailm...
.With new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of professionals wor...
.After developing a gene treatment alliance with Dyno Rehabs in 2020, Roche is actually back for eve...